UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis

Nature communications, 2020-09, Vol.11 (1), p.4767-4767, Article 4767

2020

Volltextzugriff (PDF)

A Randomized, Placebo‐Controlled Phase III Extension Trial of the Long‐Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus

Arthritis & rheumatology (Hoboken, N.J.), 2023-02, Vol.75 (2), p.253-265

2023

Volltextzugriff (PDF)

Progress in our understanding of the pathogenesis of ankylosing spondylitis

Rheumatology (Oxford, England), 2018-11, Vol.57 (suppl_6), p.vi4-vi9

2018

Volltextzugriff (PDF)

Peripheral CD8 + T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma

Nature medicine, 2020-02, Vol.26 (2), p.193-199

2020

Volltextzugriff (PDF)

Single cell analysis of spondyloarthritis regulatory T cells identifies distinct synovial gene expression patterns and clonal fates

Communications biology, 2021-12, Vol.4 (1), p.1395-1395, Article 1395

2021

Volltextzugriff (PDF)

CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses

Proceedings of the National Academy of Sciences - PNAS, 2015-08, Vol.112 (34), p.10768-10773

2015

Volltextzugriff (PDF)

Inhibiting ex-vivo Th17 responses in Ankylosing Spondylitis by targeting Janus kinases

Scientific reports, 2018-10, Vol.8 (1), p.15645-8, Article 15645

2018

Volltextzugriff (PDF)

Multi-omic single cell analysis resolves novel stromal cell populations in healthy and diseased human tendon

Scientific reports, 2020-09, Vol.10 (1), p.13939-13939, Article 13939

2020

Volltextzugriff (PDF)

Progress in our understanding of the pathogenesis of ankylosing spondylitis

Rheumatology (Oxford, England), 2018-11, Vol.57 (suppl_6), p.vi4-vi9

2018

Volltextzugriff (PDF)

Activation‐Induced Killer Cell Immunoglobulin‐like Receptor 3DL2 Binding to HLA–B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis

Arthritis & rheumatology (Hoboken, N.J.), 2016-04, Vol.68 (4), p.901-914

2016

Volltextzugriff (PDF)

Context-specific regulation of surface and soluble IL7R expression by an autoimmune risk allele

Nature communications, 2019-10, Vol.10 (1), p.4575-11, Article 4575

2019

Volltextzugriff (PDF)

Persistent stromal fibroblast activation is present in chronic tendinopathy

Arthritis research & therapy, 2017-01, Vol.19 (1), p.16-16, Article 16

2017

Volltextzugriff (PDF)

LBO1 DORIS remission in patients with SLE treated with anifrolumab or placebo during the 4-year TULIP-LTE trial: post hoc analysis

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A169-A170

2024

Volltextzugriff (PDF)

Correction: Targeting DORIS Remission and LLDAS in SLE: A Review

Rheumatology and therapy., 2024-08, Vol.11 (4), p.1059-1061

2024

Volltextzugriff (PDF)

1502 Lupus low disease activity state attainment in the phase 3 placebo-controlled TULIP long-term extension trial of anifrolumab

Lupus science & medicine, 2024-05, Vol.11 (Suppl 2), p.A114-A115

2024

Volltextzugriff (PDF)

Treating to target in psoriatic arthritis: assessing real-world outcomes and optimising therapeutic strategy for adults with psoriatic arthritis-study protocol for the MONITOR-PsA study, a trials within cohorts study design

Trials, 2021-03, Vol.22 (1), p.185-185, Article 185

2021

Volltextzugriff (PDF)

Targeting DORIS Remission and LLDAS in SLE: A Review

Rheumatology and therapy., 2023-12, Vol.10 (6), p.1459-1477

2023

Volltextzugriff (PDF)

Novel Therapeutic Targets in Axial Spondyloarthritis

Current treatment options in rheumatology, 2018, Vol.4 (2), p.174-182

2018

Volltextzugriff (PDF)

RORγt inhibitors suppress T(H)17 responses in inflammatory arthritis and inflammatory bowel disease

Journal of allergy and clinical immunology, 2016-03, Vol.137 (3), p.960

2016

Volltextzugriff (PDF)

Role of lymphocytes producing GM-CSF in human spondyloarthritis

The Lancet (British edition), 2017-02, Vol.389, p.S21-S21

2017

Volltextzugriff (PDF)

Development and implementation of 'A guide to PPIE - Early Integration into Research Proposals' in a multi-disciplinary consortium

Rheumatology (Oxford, England), 2024-03, Vol.63 (3), p.e88-e91

2024

Volltextzugriff (PDF)

Towards a novel clinical outcome assessment for systemic lupus erythematosus: first outcomes of an international taskforce

Nature reviews. Rheumatology, 2023-09, Vol.19 (9), p.592-602

2023

Volltextzugriff (PDF)

The principles of neoplasia and oncology

Surgery (Oxford), 2021-04, Vol.39 (4), p.181-187

2021

Volltextzugriff (PDF)

Towards stratified treatment of JIA: machine learning identifies subtypes in response to methotrexate from four UK cohorts

EBioMedicine, 2024-02, Vol.100, p.104946, Article 104946

2024

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Aktive Filter

KollektionBMJ Journals Archiv - DFG Nationallizenzen

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(41)

Publikationsform

Sprache

Englisch
(44)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis

A Randomized, Placebo‐Controlled Phase III Extension Trial of the Long‐Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus

Progress in our understanding of the pathogenesis of ankylosing spondylitis

Peripheral CD8 + T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma

Single cell analysis of spondyloarthritis regulatory T cells identifies distinct synovial gene expression patterns and clonal fates

CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses

Inhibiting ex-vivo Th17 responses in Ankylosing Spondylitis by targeting Janus kinases

Multi-omic single cell analysis resolves novel stromal cell populations in healthy and diseased human tendon

Progress in our understanding of the pathogenesis of ankylosing spondylitis

Activation‐Induced Killer Cell Immunoglobulin‐like Receptor 3DL2 Binding to HLA–B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis

Context-specific regulation of surface and soluble IL7R expression by an autoimmune risk allele

Persistent stromal fibroblast activation is present in chronic tendinopathy

LBO1 DORIS remission in patients with SLE treated with anifrolumab or placebo during the 4-year TULIP-LTE trial: post hoc analysis

Optimising psoriatic arthritis therapy with immunological methods to increase standard evaluation: the protocol of an open-label multicentre, parallel-group, two-arm randomised controlled study evaluation precision medicine approach in the treatment of psoriatic arthritis

Correction: Targeting DORIS Remission and LLDAS in SLE: A Review

1502 Lupus low disease activity state attainment in the phase 3 placebo-controlled TULIP long-term extension trial of anifrolumab

Treating to target in psoriatic arthritis: assessing real-world outcomes and optimising therapeutic strategy for adults with psoriatic arthritis-study protocol for the MONITOR-PsA study, a trials within cohorts study design

Targeting DORIS Remission and LLDAS in SLE: A Review

Novel Therapeutic Targets in Axial Spondyloarthritis

RORγt inhibitors suppress T(H)17 responses in inflammatory arthritis and inflammatory bowel disease

Role of lymphocytes producing GM-CSF in human spondyloarthritis

Development and implementation of 'A guide to PPIE - Early Integration into Research Proposals' in a multi-disciplinary consortium

Towards a novel clinical outcome assessment for systemic lupus erythematosus: first outcomes of an international taskforce

The principles of neoplasia and oncology

Towards stratified treatment of JIA: machine learning identifies subtypes in response to methotrexate from four UK cohorts

Aktive Filter

Suchergebnisse filtern